CP

CannaPharmaRx IncOOTC CPMD Stock Report

Last reporting period 30 Sep, 2023

Updated 20 Dec, 2024

Last price

Market cap $B

0.004

Micro

Exchange

OOTC - OTC

CPMD Stock Analysis

CP

Uncovered

CannaPharmaRx Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.004

Dividend yield

Shares outstanding

257.57 B

CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The firm's principal business activities are to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. Its activities are centered around three projects, including the Hanover Project; the Great Northern Project; and the acquisition of Sunniva Medical, Inc. and development of a cannabis cultivation facility. Its Hanover facility in Ontario includes 10 acres of land and approximately 48.8 thousand square foot growing space to produce about 9.6 thousand kilograms (kg) of cannabis annually.

View Section: Eyestock Rating